β-lactam inhibitors of human cytomegalovirus protease.

被引:0
|
作者
Ogilvie, WW [1 ]
Yoakim, C [1 ]
Cameron, DR [1 ]
Chabot, C [1 ]
Guse, I [1 ]
Hache, B [1 ]
Naud, J [1 ]
O'Meara, JA [1 ]
Plante, R [1 ]
Deziel, R [1 ]
机构
[1] Boehringer Ingelheim Canada Ltd, Biomega Res Div, Quebec City, PQ H7S 2G5, Canada
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
009-MEDI
引用
收藏
页码:U863 / U863
页数:1
相关论文
共 50 条
  • [31] Silanediol analogs of the hydrated carbonyl as a new class of aspartic protease inhibitors. Inhibition of the HIV protease.
    Sieburth, SM
    Chen, CA
    Glekas, A
    Hewitt, GW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U413 - U413
  • [32] The synthesis of azapeptidomimetic β-lactam molecules as potential protease inhibitors
    Malachowski, WP
    Tie, C
    Wang, K
    Broadrup, RL
    JOURNAL OF ORGANIC CHEMISTRY, 2002, 67 (25): : 8962 - 8969
  • [33] Small peptide-based inhibitors of the hepatitis C virus serine protease.
    Narjes, F
    Colarusso, S
    Gerlach, B
    Koehler, K
    Koch, U
    Steinkühler, C
    Bazzo, R
    Sollazzo, M
    Altamura, S
    De Francesco, R
    Matassa, VG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U539 - U540
  • [34] Flexibility and function in HIV protease.
    Torchia, DA
    FASEB JOURNAL, 1996, 10 (06): : C10 - C10
  • [35] Identification of a novel peroxisomal protease.
    Stewart, MQ
    van Dijk, R
    Goodman, JM
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 110A - 110A
  • [36] Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease
    Dhanak, D
    Keenan, RM
    Burton, G
    Kaura, A
    Darcy, MG
    Shah, DH
    Ridgers, LH
    Breen, A
    Lavery, P
    Tew, DG
    West, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (24) : 3677 - 3682
  • [37] Structure-activity relationships for macrocyclic peptidomimetic inhibitors of HIV-1 protease.
    Abbenante, G
    Bergman, DA
    Brinkworth, RI
    March, DR
    Reid, RC
    Hunt, PA
    James, IW
    Dancer, RJ
    Garnham, B
    Stoermer, ML
    Fairlie, DP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (21) : 2531 - 2536
  • [38] Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease.: 1.: The α-methyl-trans-lactam template
    Borthwick, AD
    Angier, SJ
    Crame, AJ
    Exall, AM
    Haley, TM
    Hart, GJ
    Mason, AM
    Pennell, AMK
    Weingarten, GG
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (23) : 4452 - 4464
  • [39] Inactivation of the human cytomegalovirus protease by diisopropylfluorophosphate
    Hesson, T
    Tsarbopoulos, A
    Taremi, SS
    Prosise, WW
    Butkiewicz, N
    DasMahapatra, B
    Cable, M
    VanLe, H
    Weber, PC
    TECHNIQUES IN PROTEIN CHEMISTRY VIII, 1997, 8 : 257 - 266
  • [40] Activity in monomers of human cytomegalovirus protease
    Holwerda, B
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 259 (02) : 370 - 373